John Flanagan

Title: John Flanagan: Innovator in Immunoassays and Biomarker Diagnostics

Introduction

John Flanagan is a notable inventor based in Hercules, California. He has made significant contributions to the field of immunoassays and biomarker diagnostics. With a total of 4 patents, Flanagan's work focuses on innovative methods for detecting specific antibodies and diagnosing liver conditions.

Latest Patents

Flanagan's latest patents include an immunoassay for the detection of specific IgG, IgM, and IgG/IgM antibodies in biological samples suspected of Lyme infection. This immunoassay can be performed using a standard format or on an automated platform. It utilizes specific chimeric peptides and outer surface protein types to enhance detection accuracy. Another significant patent involves a method for diagnosing Non-Alcoholic Steatohepatitis (NASH) and assessing hepatic fibrosis status based on the levels of particular biomarkers. This invention also includes a kit designed for effective diagnosis and treatment of patients.

Career Highlights

Throughout his career, John Flanagan has worked with prominent companies such as Bio-Rad Laboratories, Inc. and Bio-Rad Europe GmbH. His experience in these organizations has contributed to his expertise in the field of diagnostics and immunology.

Collaborations

Flanagan has collaborated with professionals like Michelle Delanoy and Audrey Arjomandi, enhancing his research and development efforts in the industry.

Conclusion

John Flanagan's innovative work in immunoassays and biomarker diagnostics has made a significant impact in the medical field. His contributions continue to advance the detection and treatment of various health conditions.